341 related articles for article (PubMed ID: 25885288)
1. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
[TBL] [Abstract][Full Text] [Related]
2. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting.
Harvey J; Thomas C; Wood B; Hardie M; Dessauvagie B; Combrinck M; Frost FA; Sterrett G
Pathology; 2015 Jan; 47(1):13-20. PubMed ID: 25474507
[TBL] [Abstract][Full Text] [Related]
3. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.
Vörös A; Csörgő E; Nyári T; Cserni G
Pathobiology; 2013; 80(3):111-8. PubMed ID: 23258384
[TBL] [Abstract][Full Text] [Related]
4. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
[TBL] [Abstract][Full Text] [Related]
5. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
Jing N; Fang C; Williams DS
Pathology; 2017 Jun; 49(4):371-378. PubMed ID: 28450087
[TBL] [Abstract][Full Text] [Related]
6. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.
Varga Z; Diebold J; Dommann-Scherrer C; Frick H; Kaup D; Noske A; Obermann E; Ohlschlegel C; Padberg B; Rakozy C; Sancho Oliver S; Schobinger-Clement S; Schreiber-Facklam H; Singer G; Tapia C; Wagner U; Mastropasqua MG; Viale G; Lehr HA
PLoS One; 2012; 7(5):e37379. PubMed ID: 22662150
[TBL] [Abstract][Full Text] [Related]
7. Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M; Soler-Monsó T; Petit A; Azcarate J; Lasheras A; Artal C; Gil M; Falo C; Pla MJ; Matias-Guiu X
Virchows Arch; 2019 Feb; 474(2):169-176. PubMed ID: 30465110
[TBL] [Abstract][Full Text] [Related]
8. Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment.
Kwon AY; Park HY; Hyeon J; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Cho SY; Cho EY
PLoS One; 2019; 14(2):e0212309. PubMed ID: 30785924
[TBL] [Abstract][Full Text] [Related]
9. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.
Mengel M; von Wasielewski R; Wiese B; Rüdiger T; Müller-Hermelink HK; Kreipe H
J Pathol; 2002 Nov; 198(3):292-9. PubMed ID: 12375261
[TBL] [Abstract][Full Text] [Related]
10. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
[TBL] [Abstract][Full Text] [Related]
12. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable.
Morimoto M; Bando Y; Nakagawa M; Takechi H; Yoshida T; Honda J; Tadokoro Y; Moriya T; Sasa M; Tangoku A
Breast Cancer; 2016 Jul; 23(4):577-82. PubMed ID: 25808597
[TBL] [Abstract][Full Text] [Related]
14. A new Ki-67 / E-cadherin cocktail reduces inter-observer variation of the calculated proliferative index.
Bubis G; Hilly O; Bubis R; Halpern M; Schwartz A; Koren R; Rath-Wolfson L
Pathol Oncol Res; 2013 Oct; 19(4):875-9. PubMed ID: 23832820
[TBL] [Abstract][Full Text] [Related]
15. An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.
Papathomas TG; Pucci E; Giordano TJ; Lu H; Duregon E; Volante M; Papotti M; Lloyd RV; Tischler AS; van Nederveen FH; Nose V; Erickson L; Mete O; Asa SL; Turchini J; Gill AJ; Matias-Guiu X; Skordilis K; Stephenson TJ; Tissier F; Feelders RA; Smid M; Nigg A; Korpershoek E; van der Spek PJ; Dinjens WN; Stubbs AP; de Krijger RR
Am J Surg Pathol; 2016 Apr; 40(4):569-76. PubMed ID: 26685085
[TBL] [Abstract][Full Text] [Related]
16. Her2 negative luminal breast carcinoma and Ki-67 evaluation.
Pavlakis K; Vrekoussis T; Tsipoura A; Tsenga A; Arapantoni-Dadioti P; Gavresea T; Messini I; Barbounis V
Breast; 2012 Aug; 21(4):529-33. PubMed ID: 22647834
[TBL] [Abstract][Full Text] [Related]
17. High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study.
Lacroix-Triki M; Mathoulin-Pelissier S; Ghnassia JP; Macgrogan G; Vincent-Salomon A; Brouste V; Mathieu MC; Roger P; Bibeau F; Jacquemier J; Penault-Llorca F; Arnould L
Eur J Cancer; 2006 Nov; 42(17):2946-53. PubMed ID: 16989997
[TBL] [Abstract][Full Text] [Related]
18. The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.
Vörös A; Csörgő E; Kővári B; Lázár P; Kelemen G; Cserni G
Pathol Oncol Res; 2014 Apr; 20(2):391-7. PubMed ID: 24202856
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
Tunis Med; 2016 Oct; 94(10):587-593. PubMed ID: 28972249
[TBL] [Abstract][Full Text] [Related]
20. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
